Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Horcajada

Showing results (61-70 of 175) with videos related to

Pageof 18
Sort By:
International Journal of Antimicrobial Agents|July 19, 2016
Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida sppS Grau, S Luque, D Echeverría-Esnal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumoniaJosé A Martínez, Juan P Horcajada, Manuel Almela, et al.
Journal of Clinical Microbiology|June 16, 2005
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterpartsJuan P Horcajada, Sara Soto, Abby Gajewski, et al.
Microorganisms|March 26, 2022
A Descriptive Analysis of Urinary ESBL-Producing-<i>Escherichia coli</i> in Cerdanya HospitalLorena Patrícia Gaviria, Lourdes Montsant, Carlos Azuaje, et al.
Open Forum Infectious Diseases|January 29, 2020
A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)Juan P Horcajada, Robert A Salata, Rodolfo Álvarez-Sala, et al.
Journal of Chemotherapy (Florence, Italy)|December 3, 2010
Factors associated with adherence to guidelines for the use of tigecycline in a tertiary care hospitalS Grau, D Conde-Estévez, S Luque, et al.
International Orthopaedics|March 22, 2017
C-reactive protein may misdiagnose prosthetic joint infections, particularly chronic and low-grade infectionsDaniel Pérez-Prieto, María E Portillo, Lluís Puig-Verdié, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Corrigendum to "Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study" [International Journal of Antimicrobial Agents, Volume 54, Issue 5 (2019) 572-578]D Echeverria-Esnal, L Sorli, N Prim, et al.
International Journal of Antimicrobial Agents|September 3, 2019
Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative studyD Echeverria-Esnal, L Sorli, N Prim, et al.
International Journal of Pharmaceutics|August 13, 2016
In vivo behavior of MIL-100 nanoparticles at early times after intravenous administrationT Simon-Yarza, T Baati, F Neffati, et al.
Pageof 18

Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
International Journal of Antimicrobial Agents|July 19, 2016
Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida sppS Grau, S Luque, D Echeverría-Esnal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumoniaJosé A Martínez, Juan P Horcajada, Manuel Almela, et al.
Journal of Clinical Microbiology|June 16, 2005
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterpartsJuan P Horcajada, Sara Soto, Abby Gajewski, et al.
Microorganisms|March 26, 2022
A Descriptive Analysis of Urinary ESBL-Producing-<i>Escherichia coli</i> in Cerdanya HospitalLorena Patrícia Gaviria, Lourdes Montsant, Carlos Azuaje, et al.
Open Forum Infectious Diseases|January 29, 2020
A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)Juan P Horcajada, Robert A Salata, Rodolfo Álvarez-Sala, et al.
Journal of Chemotherapy (Florence, Italy)|December 3, 2010
Factors associated with adherence to guidelines for the use of tigecycline in a tertiary care hospitalS Grau, D Conde-Estévez, S Luque, et al.
International Orthopaedics|March 22, 2017
C-reactive protein may misdiagnose prosthetic joint infections, particularly chronic and low-grade infectionsDaniel Pérez-Prieto, María E Portillo, Lluís Puig-Verdié, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Corrigendum to "Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study" [International Journal of Antimicrobial Agents, Volume 54, Issue 5 (2019) 572-578]D Echeverria-Esnal, L Sorli, N Prim, et al.
International Journal of Antimicrobial Agents|September 3, 2019
Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative studyD Echeverria-Esnal, L Sorli, N Prim, et al.
International Journal of Pharmaceutics|August 13, 2016
In vivo behavior of MIL-100 nanoparticles at early times after intravenous administrationT Simon-Yarza, T Baati, F Neffati, et al.
Pageof 18